论文部分内容阅读
慢性肺心病加重期32例,其中16例(男14例,女2例;年龄61±s11a),用藻酸双酯钠100mg溶于10％葡萄糖液400mL中,静滴,qd,20d为一个疗程。另16例为对照组(男13例,女3例,年龄58±12a)除未用PSS外,其它治疗和疗程与PSS组基本相同。结果PSS组的血液流变学指标和临床疗效都明显优于对照组(P<0.05)。未发现明显不良反应
Chronic pulmonary heart disease exacerbation in 32 cases, of which 16 cases (14 males and 2 females; age 61 ± s11a), 100mg sodium alginate dissolved in 10% glucose solution 400mL, intravenous infusion, qd, 20d as a Course of treatment. The other 16 patients were control group (13 males and 3 females, age 58 ± 12a) except PSS, the other treatment and treatment and PSS group is basically the same. Results The hemorheological parameters and clinical efficacy of PSS group were significantly better than those of the control group (P <0.05). No obvious adverse reactions were found